Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, shared on LinkedIn:
”I recently had the incredible opportunity to participate in the Plasma Protein Therapeutics Association (PPTA) meetings, both at the Plasma Protein Forum and the Business Forum.
Engaging with fellow industry members during these discussions was enlightening and enriching.
Speaking on a panel at the Business Forum—a meeting dedicated solely to plasma industry members—was a particular highlight.
We delved into crucial topics like ethical decision-making, the importance of industry collaboration, and the need for a broader industry representation in PPTA, which are crucial for driving progress in our field.
I’m proud to represent Takeda and BioLife Plasma Services and contribute to conversations on how we can collectively shape the future, ensure ethical practices, and meet patient needs.
Advocacy, transparency, and education remain paramount as we work towards improving both understanding and perception of the plasma industry across the globe.
Grateful for the opportunity to engage and learn, I look forward to continuing these important efforts alongside my esteemed colleagues to work collectively and collaboratively to meet patient needs!”

Stay updated with Hemostasis Today.
-
Dec 11, 2025, 16:18Caitlin Raymond’s Commentary on Artificial Intelligence in Transfusion Medicine is Out!
-
Dec 11, 2025, 15:20Giles Platford on Takeda’s 5 Year Deal with WFH for The Humanitarian Aid Program!
-
Dec 11, 2025, 15:05Kristof Vercruysse on ”First in Human” Presented at ASH25
-
Dec 11, 2025, 13:59Jeff Schaffnit Shares Sanofi’s Patient Advocacy Voices Series with Caroline Kruse
-
Dec 11, 2025, 12:50Harlan Krumholz on Half-Life of Evidence and The Need for Real-Time Trials
-
Dec 11, 2025, 12:34Riitta Lassila on LMWH Benefits in COVID19
-
Dec 11, 2025, 12:30A Neutrophil-Mesangial Cell Axis Promotes Glomerular Injury in Lupus Nephritis
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
